Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
home builders
March 25, 2025 11:39 AM 2 min read

KB Home Analyst Says Outlook Could Still 'Prove Optimistic,' While Flagging Cost Pressure Risks

by Priya Nigam Benzinga Staff Writer
Follow

ArticleFeaturedTickersList12345!!!

Shares of KB Home (NYSE:KBH) traded lower on Tuesday following the company’s release of disappointing fiscal first-quarter revenue results after the market closed on Monday.

The company reported its results amid an exciting earnings season. Here are some key analyst takeaways.

RBC Capital Markets On KB Home

Analyst Mike Dahl reiterated a Sector Perform rating, while reducing the price target from $67 to $63.

KB Home reported soft quarterly results, with orders down 17% year-on-year versus its "roughly flat" guidance, Dahl said in a note. While a miss was expected, the magnitude was much higher than feared, he added.

Management cut its full-year gross margin guide to 19.2%-20.0%, from their prior projection of 20%-21%, with the fiscal second-quarter guidance of 19.1%-19.5% coming in below consensus of 20.1%, the analyst stated. The company's guidance could still "prove optimistic in a softer/competitive environment with potential increased cost pressures," he wrote.

Check out other analyst stock ratings.

Keefe, Bruyette & Woods On KB Home

Analyst Jade Rahmani maintained a Market Perform rating and price target of $76.

KB Home's earnings of $1.49 per share missed consensus of $1.57 per share, with deliveries of 2,770 units declining by a higher-than-expected 9% year-on-year, Rahmani said. The company's fiscal second-quarter guidance implies a midpoint of earnings of $1.45 per share versus estimates of $1.89 per share, he added.

Management lowered their full-year housing revenue from $7.0-$7.5 billion to $6.6-$7.0 billion, average selling prices from $488,000-$498,000 to $480,000-$495,000, and gross margins from 20%-21% to 19.2%-20.0%, the analyst stated. "This implies midpoint EPS of approx. $7.22 vs. our $8.25E," he further wrote.

KBH Price Action: Shares of KB Home were down 3% to $59.91 at the time of publication Tuesday.

Read More:

  • Top 5 Trending Stocks: Nike, Quantum Computing, Fedex, D-Wave Quantum, And Tesla

Image created using artificial intelligence via Midjourney.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
Top StoriesExpert IdeasRBC Capital MarketsStories That Matter
KBH Logo
KBHKB Home
$57.54-%
Overview
KBH Logo
KBHKB Home
$57.54-%
Overview
Comments
Loading...